Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Eli Lilly and Company announced that Foundayo (orforglipron) is now available t...
According to the joint research plan, the companies will partner on two programm...
Bofanglutide is a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) d...
The acquisition aims to enhance Everest Medicines’ presence and commercial capab...
The milestone increases Jeito’s assets under management to €1.6bn, following the...
The Organisation of Pharmaceutical Producers of India (OPPI) has announced a st...
Glenmark Pharmaceuticals has received final approval from the United States Foo...
Global pharma major Lupin Limited (Lupin) today announced that it has received ...
Merck, a leading science and technology company, announced the expansion of its...
Vertex has licensed the technology for use in up to three drug targets, as part ...
MineBio will supply RoosterBio’s complete platform of products, having already o...
Approval confirms bioequivalence to Farxiga for approved indications The post ...
Denosumab biosimilars made available through specialty pharmacies and healthcar...
Approval grants eligibility for 180-day shared generic drug exclusivity The pos...
The transaction will expand Neurocrine’s portfolio in endocrinology and rare dis...
The funding will be used for commercial readiness and the potential US launch of...
